全文获取类型
收费全文 | 525篇 |
免费 | 58篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 16篇 |
妇产科学 | 3篇 |
基础医学 | 54篇 |
口腔科学 | 28篇 |
临床医学 | 50篇 |
内科学 | 158篇 |
皮肤病学 | 17篇 |
神经病学 | 45篇 |
特种医学 | 67篇 |
外科学 | 51篇 |
综合类 | 3篇 |
预防医学 | 19篇 |
眼科学 | 10篇 |
药学 | 7篇 |
中国医学 | 1篇 |
肿瘤学 | 48篇 |
出版年
2024年 | 2篇 |
2023年 | 14篇 |
2022年 | 2篇 |
2021年 | 12篇 |
2020年 | 11篇 |
2019年 | 7篇 |
2018年 | 14篇 |
2017年 | 15篇 |
2016年 | 17篇 |
2015年 | 15篇 |
2014年 | 18篇 |
2013年 | 27篇 |
2012年 | 20篇 |
2011年 | 22篇 |
2010年 | 20篇 |
2009年 | 26篇 |
2008年 | 18篇 |
2007年 | 22篇 |
2006年 | 16篇 |
2005年 | 11篇 |
2004年 | 8篇 |
2003年 | 16篇 |
2002年 | 11篇 |
2001年 | 16篇 |
2000年 | 13篇 |
1999年 | 8篇 |
1998年 | 18篇 |
1997年 | 16篇 |
1996年 | 15篇 |
1995年 | 7篇 |
1994年 | 11篇 |
1993年 | 9篇 |
1992年 | 4篇 |
1991年 | 7篇 |
1990年 | 9篇 |
1989年 | 16篇 |
1988年 | 14篇 |
1987年 | 6篇 |
1986年 | 11篇 |
1985年 | 10篇 |
1984年 | 10篇 |
1983年 | 4篇 |
1982年 | 8篇 |
1980年 | 4篇 |
1979年 | 2篇 |
1978年 | 5篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1925年 | 1篇 |
1924年 | 1篇 |
排序方式: 共有585条查询结果,搜索用时 0 毫秒
1.
Marie Warrer Petersen Tine Sylvest Meyhoff Marie Helleberg Maj-Brit Nørregaard Kjær Anders Granholm Carl Johan Steensen Hjortsø Thomas Steen Jensen Morten Hylander Møller Peter Buhl Hjortrup Mik Wetterslev Gitte Kingo Vesterlund Lene Russell Vibeke Lind Jørgensen Klaus Tjelle Thomas Benfield Charlotte Suppli Ulrik Anne Sofie Andreasen Thomas Mohr Morten H. Bestle Lone Musaeus Poulsen Mette Friberg Hitz Thomas Hildebrandt Lene Surland Knudsen Anders Møller Christoffer Grant Sølling Anne Craveiro Brøchner Bodil Steen Rasmussen Henrik Nielsen Steffen Christensen Thomas Strøm Maria Cronhjort Rebecka Rubenson Wahlin Stephan Jakob Luca Cioccari Balasubramanian Venkatesh Naomi Hammond Vivekanand Jha Sheila Nainan Myatra Christian Gluud Theis Lange Anders Perner 《Acta anaesthesiologica Scandinavica》2020,64(9):1365-1375
Introduction
Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.Methods
The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.Discussion
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.2.
3.
Anders Wahlin Lorentz Brinch Per Hrnsten Stein A. Evensen Gunnar
berg Bengt Simonsson Michael Hedenus 《European journal of haematology》1997,58(4):233-240
Abstract: The results of an intensive treatment program for patients 16–60 yr of age with de novo acute myeloid leukemia are presented. The patients were given conventional induction treatment with daunorubicin and cytarabine. Patients not entering complete remission (CR) after 1 course of daunorubicin/cytarabine were given 1 course of amsacrine/etoposide/cytarabine. Those entering complete remission received 3 consolidation courses using mitoxantrone, etoposide, amsacrine and cytarabine. One hundred and eighteen patients were enrolled. Complete remission was attained after 1–2 courses in 90 patients (76%). Another 6 patients reached CR after 3–4 induction courses for a total CR rate of 81%. If feasible, patients were offered either allogeneic or unpurged autologous bone marrow transplantation. Twenty-four patients underwent allogeneic bone marrow transplantation; 15 in first remission, 8 in second remission, 1 in early relapse. Thirty patients below 56 yr of age underwent autologous bone marrow transplantation in first remission. The overall probability of survival at 4 yr was 34%, and for patients below 40 yr of age 50%. Leukemia-free survival was 35% for the whole cohort of patients; 52% for patients below 40 yr of age. Patients undergoing allogeneic or autologous bone marrow transplantation in first remission had an overall survival of 86% and 47%, respectively, while the probability of leukemia-free survival in these groups was 87% vs. 40% at 4 yr. The CR rate and long-term results of this intensive treatment program compare favorably with other recent studies using intensive consolidation with allogeneic or autologous bone marrow transplantation or high dose cytarabine. 相似文献
4.
Sequential contrast-enhanced MR imaging of the penis 总被引:1,自引:0,他引:1
5.
Chlamydial etiology of acute lower respiratory tract infections in children in the Sudan 总被引:2,自引:0,他引:2
B Herrmann MAM Salih BE Yousif O Abdelwahab P-A Mårdh 《Acta paediatrica (Oslo, Norway : 1992)》1994,83(2):169-172
The role of Chlamydia pneumoniae in 110 Sudanese children with signs of acute lower respiratory tract infections (ALRI) was investigated. Four (3.6%) had evidence of C. pneumoniae infection, of whom 3 were culture-positive, while 1 had an antibody response suggesting a recent infection. IgG antibodies at a titer of ≥1:32 to C. pneumoniae, Chlamydia psittaci and Chlamydia trachomatis were detected in 27 (24.5%), 27 (24.5%) and 7 (6.4%) of the 110 ALRI cases, respectively. C. pneumoniae, C. trachomatis or C. psittaci were not detected in nasopharyngeal secretions from any of 110 patients when fluorescence-labeled specific monoclonal antibodies were used. In a seroepidemiological survey, 318 healthy Sudanese persons aged between 1 month and 67 years were studied for C. pneumoniae antibodies. 相似文献
6.
P. VON DEN DRIESCH C. STEFFAN A. ZÖBE O.P. HORNSTEIN 《Clinical and experimental dermatology》1994,19(3):274-277
We report the case of a 39-year-old female patient suffering from Sweet's syndrome after an upper respiratory tract infection. Cyclosporin A at a dose of 10 mg/kg per day was given as initial treatment. Skin lesions and general malaise resolved within 9 days. The cyclosporin dose was decreased within 21 days, without recurrence of the eruption. Cyclosporin is a potent inhibitor of T lymphocytes, but affects granulocyte and monocyte functions as well. Success of treatment in our case shows that cyclosporin represents an alternative to steroid treatment in patients with Sweet's syndrome. 相似文献
7.
Observations on two members of the Swedish family with congenital dyserythropoietic anaemia,type III
S. N. Wickramasinghe A. Wahlin D. Anstee S. F. Parsons G. Stopps I. Bergstrom M. Eriksson H. Sandstrom S. Shiels 《European journal of haematology》1993,50(4):213-221
Abstract: Two affected individuals of the Swedish family with CDA, type III, in which the disease is transmitted as an autosomal dominant character, were studied. Both cases displayed features hitherto undescribed in this family but described in patients with CDA, type III, in whom the inheritance may have been as an autosomal recessive character. Such features were: (a) haemosiderinuria, (b) grossly disorganised erythroblast nuclei, (c) differences in the ultrastructural appearances of individual nuclei within the same multinucleate erythroblast and (d) intraerythroblastic inclusions resembling precipitated globin chains. In both cases the giant mononucleate erythroblasts and the multinucleate erythroblasts had total DNA contents up to 28c (1c = haploid DNA content) and 48c respectively, and some DNA synthesising bi- and multinucleate erythroblasts contained one or more nuclei which were unlabelled with 3H-thymidine. These findings are similar to those in patients with the autosomal recessive type of disease. Thus no major phenotypic differences are yet apparent between cases of CDA, type III, with different patterns of inheritance. Analysis of the surface erythrocyte proteins of the 2 Swedish CDA, type III, patients with monoclonal antibodies recognising Band 3, glycophorins A, B, C and D, Rh, CD44, CD47, CD55, CD58, CD59, Lutheran, Kell, LW and acetylcholinesterase did not reveal any gross abnormality of expression of these proteins. A slightly altered expression of blood group antigens A and H was revealed by the lectins Dolichos biflorus and Ulex europaeus and the Mr of Band 3 as judged by SDS polyacrylamide gel electrophoresis was also slightly reduced, suggesting that there may be minor alterations in the degree of N-glycosylation of some red cell membrane constituents. 相似文献
8.
Dynamic particle image velocimetry (PIV) was applied to the study of the flow field associated with prosthetic heart valves.
The results were compared with those of laser Doppler anemometry (LDA). Anatomically and antianatomically oriented Jyros (JR)
and St. Jude Medical (SJM) valves were compared in the mitral position to study the effects of valve design on the downstream
flow field. The experimental program used a dynamic PIV system utilizing high-speed, high-resolution video to map the true
time-resolved velocity field inside the simulated ventricle. This system was complemented by a study using the more traditional
LDA system for comparison. Based on the experimental data, the following general conclusions can be made. High-resolution
dynamic PIV can capture true chronological changes in the velocity and turbulence fields. It also produces very detailed velocity
and turbulence information comparable to the LDA results. In the vertical measuring plane that passes both the center of the
aortic and mitral valves (A-A section), the two valves (the SJM and the JR) show distinct circulatory flow patterns when the
valve is installed in the antianatomical orientation. Small differences in valve design can generate noticeable differences,
particularly during the accelerating flow phase. The SJM valve maintains a relatively high velocity through the central orifice;
the curved leaflets of the JR valve generate higher velocities with a divergent flow during the accelerating and peak flow
phases. In the velocity field directly below the mitral valve and normal to the previous measuring plane (B-B section), where
characteristic differences in valve design will be visible, symmetrical twin circulations were observed because of the divergent
nature of the flow generated by the two inclined half-disks installed in the antianatomical orientation. The SJM valve, with
a central downward flow near the valve, is contrasted with the JR valve, which has a peripheral downward circulation with
higher, turbulent stresses. 相似文献
9.
10.
t(6;9) in bone marrow cells in two patients with sarcoidosis and acute myeloid leukemia 总被引:1,自引:0,他引:1
I Nordenson L Bjermer G Holmgren P H?rnsten A Wahlin 《Cancer Genetics and Cytogenetics》1989,38(2):297-300
A t(6;9) was seen in bone marrow aspirates from two patients with sarcoidosis who developed acute myeloid leukemia. This is a new observation not previously reported. 相似文献